Hematology / Medical Oncology Fellowship Training Program
Overview
The Hematology/Medical Oncology Fellowship Program is an ACGME-accredited combined three-year training program supported by two T32 grants for training in hematology and in cancer medicine. Offered in conjunction with the Division of Hematology, the program leads to board certification in hematology and medical oncology and both divisions are dedicated to providing outstanding training for clinical hematologists and oncologists, as well as for physician-scientists.
In addition, the Division of Oncology is a major component of the NYU Cancer Institute and its NCI-designated Cancer Center. Fellows benefit from the role the Division plays in the administration, clinical research patient care of the Cancer Institute.
Clinical and Research Training
The Division of Medical Oncology works closely with the Division of Hematology to provide fellows with an outstanding education in hematological and solid tumors. They are exposed to a wide spectrum of medical cases, patients and technologies through the combined yet distinct clinical resources of NYU Medical center, including Tisch Hospital, Bellevue Hospital Center, Veterans Affairs Hospital and the Hospital for Joint Diseases.
The five to six oncology fellows accepted each year begin their training with a year in Clinical Hematology, followed by a second year in Clinical Oncology. Medical Oncology fellows rotate through Tisch and Bellevue Hospitals and the VA Medical Center New York, where they serve as consults. A dedicated fellow is also assigned to the Hematology/Oncology Unit at both Tisch and Bellevue Hospitals throughout the year.
The third year is spent pursuing research training in a laboratory suitable to their skills and interests. For promising research candidates, an additional fourth year of laboratory training may be provided. The fellows may also pursue by pre-arrangement elective periods in palliative care and in other areas in oncology. All fellows are expected to give scholarly presentations at internal and national meetings.